Olcay Y,Jones MD PhD, Charles H, et al. A Multicenter Case-Co ntrol Study on Predictive Factors Distinguishing Childhood Leukemia From Juvenile Rheu matoid Arthritis[J]. Pediatrics,2006,117(5):840-844.
[4]
Willemse M J,Seriu T,Hettinger K,et al.Detection of minimal resid ual disease identifiles differences in treatment response between T-ALL and precur sor B-ALL[J].Blood,2002,99(12):4386-4393.
[5]
Marja J,Willemse, Taku Seriu,et al. Detection of minimal resid ual disease i dentifies differences in treatment response between T-ALL and precursor B-ALL[J]. Blood,2002,99(12):4386-4393.
[6]
Joseph M, Tuscano,Robert T,et al. Anti-CD22 ligand-blocking ant ibody HB22.7 has independent lymphomacidal properties and augments the efficacy of 90Y-DOTA- peptide-Lym-1 in lymphoma xenografts[J]. Blood,2003, 101(9):3641-3647.
[7]
Hal E,Crosswell,Robert B,et al.Pediatric Acute Biphenotypic Leuke mia(aBL):A Clinico-Pathologic Analysis of a Single Institution Experience[J]. Bl ood,2005,106:4480.
